Hefei National Biotech
Latest round
- Series A
Last raised
- Jun 2025
Total raised
- Undisclosed
Investors
- 3
About Hefei National Biotech
Based in Hefei, China, and founded in 2020, Hefei National Biotech specializes in advanced molecular diagnostics and immunodiagnostics. It has acquired High-Tech Enterprise Certificate. The founder, Xiuqing Gong, graduated with a PhD from the Hong Kong University of Science and Technology. The core team members come from Imperial College London, Waseda University in Japan, Hong Kong University of Science and Technology, etc. Hefei National Biotech specializes in molecular diagnostics and immunodiagnostics, leveraging bio-microfluidic chip technology as its core platform. The company’s flagship products include the GY-100A and GY-200A single-molecule immunoanalysers, which deliver high-precision diagnostic results for various medical conditions, particularly cancer. Their product offerings also feature test kits for prostate cancer (PSA) and cytokine triad tests, addressing specific needs in cancer screening and cytokine profiling. The company generates revenue by developing molecular in vitro diagnosis and detection technology.
Who invested in Hefei National Biotech
3 investors across 1 round
See all investors in Hefei National Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 4, 2025
Amount
Undisclosed
Investors
Questions about Hefei National Biotech
Who invested in Hefei National Biotech?
Hefei National Biotech has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hefei National Biotech raised?
Hefei National Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hefei National Biotech last raise money?
Hefei National Biotech's most recent round on record is a Series A, in Jun 2025.
What does Hefei National Biotech do?
Based in Hefei, China, and founded in 2020, Hefei National Biotech specializes in advanced molecular diagnostics and immunodiagnostics.
Where is Hefei National Biotech headquartered?
Hefei National Biotech is headquartered in Hefei, China.
Which VCs invest in companies like Hefei National Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Hefei National Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hefei National Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.